Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-020834
Filing Date
2017-11-01
Accepted
2017-11-01 17:19:15
Documents
48
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 TTPH Q3 10-Q 20170930 ttph-10q_20170930.htm 10-Q 1528288
2 EX-10.1 ttph-ex101_154.htm EX-10.1 502291
3 EX-10.2 ttph-ex102_48.htm EX-10.2 58749
4 EX-31.1 ttph-ex311_10.htm EX-31.1 17280
5 EX-31.2 ttph-ex312_9.htm EX-31.2 17532
6 EX-32.1 ttph-ex321_6.htm EX-32.1 6206
7 EX-32.2 ttph-ex322_8.htm EX-32.2 6220
8 GRAPHIC g2017110121082642015044.jpg GRAPHIC 5731
  Complete submission text file 0001564590-17-020834.txt   4523414

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ttph-20170930.xml EX-101.INS 654141
10 XBRL TAXONOMY EXTENSION SCHEMA ttph-20170930.xsd EX-101.SCH 29650
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttph-20170930_cal.xml EX-101.CAL 23761
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttph-20170930_def.xml EX-101.DEF 83806
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttph-20170930_lab.xml EX-101.LAB 231390
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttph-20170930_pre.xml EX-101.PRE 169012
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35837 | Film No.: 171169923
SIC: 2834 Pharmaceutical Preparations